A Word From our Experts
Our Thoughts on the Drug Supply Chain, Communicatoin, and DSCSA
Trust.med and Kvinta Unite to Offer Lifeline for Pharmaceutical Suppliers Struggling with United States Compliance Challenges
Press Release September 10, 2024 Learn More and Estimate Pricing Cleveland, Ohio – Trust.med, a pioneering provider of data exchange solutions, and Kvinta, a global leader in serialization technology, are excited to unveil a unified initiative designed to support pharmaceutical suppliers struggling with underperforming technology providers. This collaborative effort offers a comprehensive, cost-effective solution that … Read more
Read More
Streamlining Data Exchange Onboarding
The Electronic Product Code Information Services (EPCIS) framework plays a crucial role in enabling seamless and secure information sharing across various stakeholders in the supply chain. To ensure the robustness, reliability, and timely deployment of this system, a comprehensive testing strategy is essential. I’ve outlined our structured approach to testing both the ingestion of EPCIS data from manufacturers or suppliers (inbound) and the dissemination of this information to downstream partners (outbound).
Read More
DataX Overview
DataX offers supply chain trading partners enterprise-grade data exchange capabilities, data translation services, intuitive reporting, and cost-effective scaling. Regulatory and technological developments on the pharmaceutical and healthcare supply chain make trading partner data exchange capabilities more important than ever. DataX is a flexible, manageable, and affordable solution.
Read More
Effective EPCIS Testing
The Electronic Product Code Information Services (EPCIS) framework plays a crucial role in enabling seamless and secure information sharing across various stakeholders in the supply chain. To ensure the robustness, reliability, and timely deployment of this system, a comprehensive testing strategy is essential. I’ve outlined our structured approach to testing both the ingestion of EPCIS data from manufacturers or suppliers (inbound) and the dissemination of this information to downstream partners (outbound).
Read More
Trust.med Registry Launch
The registry is a catalog of drug product identifiers paired with manufacturer contact information. It’s searchable by National Drug Code (NDC) or Global Trade Item Number (GTIN). We developed it to enhance communication on the drug supply chain.
Read More
Supply Chain Communication
The US drug supply chain regulation envisions a secure Electronic Drug Distribution system that requires authorized trading partners to access and interact with it. So, what exactly is this system and what are your responsibilities within it?
Read More
Beyond DSCSA: Aggregation and Exceptions
DSCSA does not mandate aggregation. Does that mean you shouldn’t aggregate your data?
Of course not! Since everyone, including manufacturers, will rely on the practice of inference. Aggregation is in fact necessary for interoperable trade in the drug supply chain.
What most manufacturers and distributors don’t yet realize is that aggregated information will become a key component of their exception handling strategy and their ability to demonstrate control.
Read More
DSCSA for Pharmacies: 3 Must Knows
DSCSA for Pharmacies: 3 Must Knows Data Exchange | Partner Verification | Tracing Requests January 17th, 2023 This is the year the pharmaceutical supply chain must comply with the FDA’s Drug Supply Chain Security Act (DSCSA). These requirements must be met in order to operate within the US Drug Supply Chain. As the primary touchpoint … Read more
Read More
The Drug Manufacturer’s DSCSA Dilemma
A decade’s worth of time has expired since the Drug Supply Chain Security Act (DSCSA) was passed to help protect consumers from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful. This November marks the start of the 12 month countdown requiring pharmaceutical trading partners to comply with the law. As time quickly slips away, trading partners are still left with unanswered questions and serious operational risks if found to be non-compliant by November 27, 2023.
Read More